Document is current
Any future updates will be listed below
-
Authors
Pelizzari-Raymundo, Diana https://orcid.org/0000-0002-9071-2380
Maltret, Victoria
Nivet, Manon https://orcid.org/0000-0001-8562-9614
Pineau, Raphael
Papaioannou, Alexandra https://orcid.org/0000-0002-3470-284X
Zhou, Xingchen https://orcid.org/0000-0003-2291-8181
Caradec, Flavie
Martin, Sophie https://orcid.org/0000-0001-5173-6665
Le Gallo, Matthieu https://orcid.org/0000-0001-9085-8155
Avril, Tony https://orcid.org/0000-0002-1129-8514
Chevet, Eric https://orcid.org/0000-0001-5855-4522
Lafont, Elodie https://orcid.org/0000-0003-1978-7491
- License Information
-
More Information
Article History
Received: 31 March 2023
Revised: 18 January 2024
Accepted: 3 February 2024
First Online: 21 February 2024
Disclosure and competing interests statement
: EC is a founder of Thabor Therapeutics. The authors do not declare any conflict of interest.
